Patients should maintain open communication with their healthcare team, reporting any new or worsening cardiac symptoms promptly
And by the way: I still dont really get how this ties back into GLP-1s
We personalize titration and sideeffect management to help you lose weight safely and keep it off
While both contain semaglutide, there are crucial differences in their regulatory status, composition, and oversight that patients should understand
For instance, in the pivotal SURPASS-2 trial, patients receiving the highest tirzepatide dose (15 mg) achieved a mean body weight reduction of 11.2 kg, nearly twice that observed with semaglutide 1 mg (5.7 kg) (19)
Yes in general, GLP-1 receptor agonists like Ozempic and Mounjaro are safe for people with heart rhythm disorders